Submit a comment
Citation Information: J Clin Invest. 1972;51(2):216-223. https://doi.org/10.1172/JCI106806.
Abstract
The effect of partial pancreatectomy (80-90%) on vitamin B12 absorption was studied in the rat. The absorption of 5 ng of 57Co-labeled vitamin B12 was significantly reduced from 70 ±2.5% (mean ±SE) in control and sham-operated rats to 32 ±2.6% in partially pancreatectomized rats. Hog pancreatic extract (0.17 g/kg) improved vitamin B12 absorption from 30.0 to 61.0% in partially pancreatectomized rats but did not alter vitamin B12 absorption in control rats. Chloramphenicol did not enhance vitamin B12 absorption in partially pancreatectomized rats with pancreatic extract-improved vitamin B12 malabsorption. The partially pancreatectomized rats with pancreatic extract-improved vitamin B12 malabsorption were sacrificed and the stomach and small bowel studied in vitro to further define the pathogenesis of the vitamin B12 malabsorption. Rat gastric intrinsic factor stimulated vitamin B12 uptake by intestinal sacs prepared from partially pancreatectomized rats 3.1-fold. Gastric intrinsic factor prepared from partially pancreatectomized rats was as effective in promoting vitamin B12 uptake by rat intestinal sacs as intrinsic factor prepared from control rats. These data indicate that partially pancreatectomized rats develop an abnormality in the absorption of labeled vitamin B12 which can be corrected by pancreatic extract. The vitamin B12 malabsorption is due to neither an alteration in gastric intrinsic factor activity nor an impairment of the intrinsic factor-vitamin B12 receptor in the intestine. It is suggested that in the partially pancreatectomized rats the intrinsic factor-vitamin B12 complex exists in a form which is not available for absorption.
Authors
Philip P. Toskes, Julius J. Deren
Guidelines
The Editorial Board will only consider comments that are deemed relevant and of interest to readers. The Journal will not post data that have not been subjected to peer review; or a comment that is essentially a reiteration of another comment.
- Comments appear on the Journal’s website and are linked from the original article’s web page.
- Authors are notified by email if their comments are posted.
- The Journal reserves the right to edit comments for length and clarity.
- No appeals will be considered.
- Comments are not indexed in PubMed.
Specific requirements
- Maximum length, 400 words
- Entered as plain text or HTML
- Author’s name and email address, to be posted with the comment
- Declaration of all potential conflicts of interest (even if these are not ultimately posted); see the Journal’s conflict-of-interest policy
- Comments may not include figures
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)